Back
Olympic Steel 10K Form
Buy
56
ZEUS
Olympic Steel
Last Price:
$34.65
Seasonality Move:
-8.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | ZEUS/Olympic Steel Quarterly |
2023-11-03 | 10Q | ZEUS/Olympic Steel Quarterly |
2023-08-04 | 10Q | ZEUS/Olympic Steel Quarterly |
2023-05-05 | 10Q | ZEUS/Olympic Steel Quarterly |
2022-11-04 | 10Q | ZEUS/Olympic Steel Quarterly |
2022-08-05 | 10Q | ZEUS/Olympic Steel Quarterly |
Receive ZEUS News And Ratings
See the #1 stock for the next 7 days that we like better than ZEUS
ZEUS Financial Statistics
Sales & Book Value
Annual Sales: | $1.9B |
---|---|
Cash Flow: | $40.6M |
Price / Cash Flow: | 7.8 |
Annual Sales: | $51.44 |
Price / Book: | 0.68 |
Profitability
EPS (TTM): | 1.43000 |
---|---|
Net Income (TTM): | $16.8M |
Gross Margin: | $451.2M |
Return on Equity: | 2.95% |
Return on Assets: | 1.63% |
Olympic Steel Earnings Forecast
Key Olympic Steel Financial Ratios
-
The Gross Profit Margin over the past 31 years for ZEUS is 23.24%.
-
The Selling, General & Administrative Expenses for ZEUS have been equal to 12.59% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 71.63% of Operating Income.
-
The Net Earning history of ZEUS is 1.18% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 15 years.
Olympic Steel Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Metals & Mining |
Sector: | Materials |
Current Symbol: | ZEUS |
CUSIP: | 68162K |
Website: | olysteel.com |
Debt
Debt-to-Equity Ratio: | 0.41 |
---|---|
Current Ratio: | 3.16 |
Quick Ratio: | 1.2 |
Price-to-Earnings
Trailing P/E Ratio: | 17.67 |
---|---|
Forward P/E Ratio: | 12.34 |
ZEUS Technical Analysis vs Fundamental Analysis
Buy
56
Olympic Steel (ZEUS)
is a Buy
Is Olympic Steel a Buy or a Sell?
-
Olympic Steel stock is rated a BuyThe current Olympic Steel [ZEUS] share price is $34.81. The Score for ZEUS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.